1. Home
  2. IMRN vs NITO Comparison

IMRN vs NITO Comparison

Compare IMRN & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • NITO
  • Stock Information
  • Founded
  • IMRN 1994
  • NITO 2009
  • Country
  • IMRN Australia
  • NITO Israel
  • Employees
  • IMRN N/A
  • NITO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • NITO
  • Sector
  • IMRN Health Care
  • NITO
  • Exchange
  • IMRN Nasdaq
  • NITO NYSE
  • Market Cap
  • IMRN 10.1M
  • NITO 12.2M
  • IPO Year
  • IMRN N/A
  • NITO N/A
  • Fundamental
  • Price
  • IMRN $1.80
  • NITO $0.30
  • Analyst Decision
  • IMRN Strong Buy
  • NITO
  • Analyst Count
  • IMRN 1
  • NITO 0
  • Target Price
  • IMRN $5.00
  • NITO N/A
  • AVG Volume (30 Days)
  • IMRN 3.2K
  • NITO 1.1M
  • Earning Date
  • IMRN 03-25-2025
  • NITO 03-31-2025
  • Dividend Yield
  • IMRN N/A
  • NITO N/A
  • EPS Growth
  • IMRN N/A
  • NITO N/A
  • EPS
  • IMRN N/A
  • NITO N/A
  • Revenue
  • IMRN $4,048,286.00
  • NITO $175,308.00
  • Revenue This Year
  • IMRN N/A
  • NITO N/A
  • Revenue Next Year
  • IMRN N/A
  • NITO N/A
  • P/E Ratio
  • IMRN N/A
  • NITO N/A
  • Revenue Growth
  • IMRN 82.90
  • NITO N/A
  • 52 Week Low
  • IMRN $1.70
  • NITO $0.16
  • 52 Week High
  • IMRN $3.09
  • NITO $3.49
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 45.49
  • NITO 30.63
  • Support Level
  • IMRN $1.75
  • NITO $0.37
  • Resistance Level
  • IMRN $2.07
  • NITO $0.39
  • Average True Range (ATR)
  • IMRN 0.11
  • NITO 0.09
  • MACD
  • IMRN -0.01
  • NITO -0.02
  • Stochastic Oscillator
  • IMRN 33.61
  • NITO 6.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About NITO N2OFF INC

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork.

Share on Social Networks: